Focus Issue: Developing Therapies in Heart Failure: A New Era for Drugs and DevicesState-of-the-Art ReviewThe Future of Wearables in Heart Failure Patients
Central Illustration
Key Words
Abbreviations and Acronyms
Cited by (0)
Supported by the Duke Clinical Research Institute, Durham, North Carolina. Dr. DeVore has received research support from AstraZeneca, Amgen, American Heart Association, Bayer, Luitpold Pharmaceuticals, Medtronic, National Heart, Lung, and Blood Institute, Patient-Centered Outcomes Research Institute, and Novartis; and is a consultant for AstraZeneca, LivaNova, Mardil Medical, Novartis, and Procyrion. Dr. Hernandez has received research support from Regent, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, and Verily; and is a consultant for AstraZeneca, Bayer, Boehringer Ingelheim, Boston Scientific, Merck, and Novartis. Dr. Wosik has reported that he has no relationships relevant to the contents of this paper to disclose.